Medplus Health Services Ltd

Medplus Health Services Ltd

Medplus Health Services Ltd has disclosed reasons for encumbrance by its promoters under SEBI (SAST) Regulations, 2011. Agilemed Investments Private Limited, Lone Furrow Investments Private Limited, and Madhukar Reddy Gangadi have pledged shares with various entities.

Medplus Health Services Ltd

Medplus Health Services Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Agilemed Investments Pvt Ltd regarding the creation of a pledge of 5,00,000 shares by Madhukar Reddy Gangadi, a promoter of the company.

Medplus Health Services Ltd

Medplus Health Services Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Catalyst Trusteeship Ltd.

Medplus Health Services Ltd

Medplus Health Services Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from ICICI Prudential Mutual Fund.

Medplus Health Services Ltd

Medplus Health Services Ltd has announced the voting results and scrutinizer's report of its 20th Annual General Meeting (AGM) held on August 17, 2026, through video conferencing. The company has approved all six resolutions with the requisite majority.

Medplus Health Services Ltd

Medplus Health Services Ltd held its 20th Annual General Meeting on August 17, 2026, through video conferencing, with 134 members attending. The meeting was chaired by Gangadi Madhukar Reddy, Chairman & Managing Director and CEO, and the statutory auditors and secretarial auditors expressed unqualified opinions in their reports for the financial year 2025-2026.

Medplus Health Services Ltd

Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, has received three suspension orders for drug licenses at stores in Karnataka, resulting in potential revenue loss of Rs 0.24 lacs, Rs 0.17 lacs, and Rs 0.23 lacs respectively.

Medplus Health Services Ltd

Medplus Health Services Ltd's subsidiary Optival Health Solutions Private Limited has received a two-day suspension order for a drug license for a store in Karnataka, resulting in a potential revenue loss of Rs 0.71 lacs.

Medplus Health Services Ltd

Medplus Health Services Ltd has received a rectification of disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011 from Catalyst Trusteeship Ltd, correcting the date of acquisition of shares from June 24, 2026 to July 24, 2026.

Medplus Health Services Ltd

Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, received a five-day suspension order for a drug license of a store in Telangana due to a contravention under the Drugs and Cosmetics Act, 1940.

Medplus Health Services Ltd

Medplus Health Services Ltd has made a disclosure under SEBI (SAST) Regulations, 2011, regarding reasons for encumbrance by its promoter.

Medplus Health Services Ltd

Medplus Health Services Ltd has made a disclosure under SEBI (SAST) Regulations, 2011 regarding encumbrance by its promoter.

Medplus Health Services Ltd

Medplus Health Services Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Lone Furrow Investment Pvt Ltd on July 29, 2026.

Medplus Health Services Ltd

Medplus Health Services Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Agilemed Investments Pvt Ltd on July 29, 2026.

Medplus Health Services Ltd

Medplus Health Services Ltd has disclosed under Regulation 29(2) of SEBI (SAST) Regulations, 2011, that Catalyst Trusteeship Ltd has created a pledge over 49,00,000 equity shares of Medplus Health Services Ltd, representing 4.08% of the total diluted share capital.

Medplus Health Services Ltd

Medplus Health Services Ltd has submitted the transcript of its earnings call for Q1 FY27, which was held on July 22, 2026. The company's consolidated revenue for the quarter stood at INR18,796 million, with an operating EBITDA of INR651 million. Pharmacy operations grew by 21.8% Y-o-Y, and the pharmacy operating EBITDA stood at INR588 million. The company has opened 222 stores and closed 52, with a net addition of 146 stores during the quarter.

Medplus Health Services Ltd

Medplus Health Services Ltd has published a newspaper notice for the completion of dispatch of its 20th Annual General Meeting notice, as per Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Medplus Health Services Ltd

Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, has received three suspension orders for drug licenses of stores in Karnataka, resulting in potential revenue loss of Rs 2.40 lacs.

Medplus Health Services Ltd

Medplus Health Services Ltd has made a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a potential change in control or significant stake acquisition by ICICI Prudential Mutual Fund.

Medplus Health Services Ltd

Medplus Health Services Ltd has released its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as per SEBI regulations.